BSE Live
Mar 14, 16:00Prev. Close
396.55
Open Price
395.10
Bid Price (Qty.)
395.00 (1000)
Offer Price (Qty.)
396.55 (187)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Claris Lifesciences (in Rs. Cr.) | Dec 11 | Dec 10 | Dec 09 | Dec 08 | Dec 07 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 63.82 | 63.82 | 34.12 | 89.69 | 89.69 | |
| Total Share Capital | 63.82 | 63.82 | 34.12 | 89.69 | 89.69 | |
| Reserves and Surplus | 812.81 | 757.84 | 444.36 | 336.85 | 225.50 | |
| Total Reserves and Surplus | 812.81 | 757.84 | 444.36 | 336.85 | 225.50 | |
| Total Shareholders Funds | 876.63 | 821.66 | 478.48 | 426.54 | 315.19 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 181.72 | 184.79 | 153.49 | 330.71 | 225.55 | |
| Deferred Tax Liabilities [Net] | 60.24 | 59.01 | 56.44 | 51.78 | 31.55 | |
| Other Long Term Liabilities | 3.42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 6.36 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 251.75 | 243.80 | 209.93 | 382.48 | 257.10 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 189.49 | 175.84 | 160.52 | 0.00 | 0.00 | |
| Trade Payables | 87.86 | 122.48 | 110.93 | 0.00 | 0.00 | |
| Other Current Liabilities | 138.33 | 127.05 | 172.05 | 192.93 | 190.05 | |
| Short Term Provisions | 25.78 | 36.54 | 29.39 | 42.92 | 36.55 | |
| Total Current Liabilities | 441.46 | 461.92 | 472.89 | 235.85 | 226.61 | |
| Total Capital And Liabilities | 1,569.84 | 1,527.37 | 1,161.30 | 1,044.88 | 798.90 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 661.35 | 523.03 | 484.15 | 489.09 | 295.52 | |
| Intangible Assets | 0.19 | 5.62 | 5.62 | 3.46 | 3.88 | |
| Capital Work-In-Progress | 41.91 | 185.72 | 123.23 | 73.54 | 112.41 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 703.45 | 714.36 | 612.99 | 566.08 | 411.80 | |
| Non-Current Investments | 17.06 | 17.06 | 17.06 | 16.42 | 12.77 | |
| Deferred Tax Assets [Net] | 0.00 | 6.77 | 4.59 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 194.26 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 1.76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 916.53 | 738.19 | 634.63 | 582.49 | 424.57 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 152.11 | 136.60 | 121.64 | 104.77 | 57.43 | |
| Trade Receivables | 243.86 | 253.34 | 241.36 | 267.69 | 266.80 | |
| Cash And Cash Equivalents | 151.17 | 290.64 | 43.53 | 16.67 | 14.26 | |
| Short Term Loans And Advances | 104.86 | 108.60 | 120.14 | 73.27 | 35.83 | |
| OtherCurrentAssets | 1.31 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 653.30 | 789.18 | 526.67 | 462.39 | 374.33 | |
| Total Assets | 1,569.84 | 1,527.37 | 1,161.30 | 1,044.88 | 798.90 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 297.02 | 37.09 | 65.94 | 26.30 | 86.25 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 54.36 | 65.74 | 56.86 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 8.12 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 8.12 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 15.21 | 11.02 | 9.52 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 27.22 | 22.06 | 57.50 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 2.91 | 1.42 | 1.18 | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 276.51 | 299.19 | 294.76 | -- | -- | |
| Other Earnings | 1.48 | -- | 2.14 | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 39.98 | 39.98 | 22.92 | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 17.06 | 17.06 | 17.06 | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.12.2017
17.10.2017
31.07.2017
US FDA conducts surprise audit at Claris Life's Ahmedabad unit
27.07.2017
Claris completes injectables biz sale, to inform about transfer to shareholders by Oct